Literature DB >> 11353611

Pharmacokinetic-pharmacodynamic modeling of the electroencephalogram effect of imipenem in healthy rats.

A Dupuis1, W Couet, J Paquereau, S Debarre, A Portron, C Jamois, S Bouquet.   

Abstract

A pharmacokinetic-pharmacodynamic (PK-PD) modeling approach was developed to investigate the epileptogenic activity of imipenem in rats. Initially, animals received an intravenous infusion of imipenem at a rate of 2.65 mg min(-1) for 30 min. Blood samples were collected for drug assay, and an electroencephalogram (EEG) was recorded during infusion and postinfusion. A dramatic delay was observed between concentrations of imipenem in serum and the EEG effect; this effect was accompanied by tremors and partial seizures. Indirect-effect models failed to describe these data, which were successfully fitted using an effect compartment model. The relationship between effect and concentration at the effect site was best described by a spline function. The elimination rate constant from the effect compartment was severalfold lower than that from the central compartment. The robustness of the model was then confirmed after administering the imipenem dose over 60 and 90 min. In conclusion, the successful PK-PD modeling of the imipenem EEG effect in rats constitutes a major improvement for better prediction of the epileptogenic risk associated with this antibiotic.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11353611      PMCID: PMC90531          DOI: 10.1128/AAC.45.6.1682-1687.2001

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  40 in total

1.  Antagonistic interaction between the convulsant activities of pefloxacin and its main metabolite norfloxacin in rats.

Authors:  A Delon; L M Levasseur; M Giraudon; S Bouquet; W Couet
Journal:  Pharm Res       Date:  1999-12       Impact factor: 4.200

2.  The time of maximum effect for model selection in pharmacokinetic-pharmacodynamic analysis applied to frusemide.

Authors:  M Wakelkamp; G Alván; G Paintaud
Journal:  Br J Clin Pharmacol       Date:  1998-01       Impact factor: 4.335

3.  Characterization of four basic models of indirect pharmacodynamic responses.

Authors:  A Sharma; W J Jusko
Journal:  J Pharmacokinet Biopharm       Date:  1996-12

Review 4.  Neurotoxicity of carbapenem antibacterials.

Authors:  S R Norrby
Journal:  Drug Saf       Date:  1996-08       Impact factor: 5.606

5.  Pharmacokinetic-pharmacodynamic modeling of the electroencephalogram effect of synthetic opioids in the rat: correlation with the interaction at the mu-opioid receptor.

Authors:  E H Cox; T Kerbusch; P H Van der Graaf; M Danhof
Journal:  J Pharmacol Exp Ther       Date:  1998-03       Impact factor: 4.030

6.  Pharmacokinetic-pharmacodynamic modeling of the anticonvulsant and electroencephalogram effects of phenytoin in rats.

Authors:  O E Della Paschoa; J W Mandema; R A Voskuyl; M Danhof
Journal:  J Pharmacol Exp Ther       Date:  1998-02       Impact factor: 4.030

7.  Effects of some excitatory amino acid antagonists and drugs enhancing gamma-aminobutyric acid neurotransmission on pefloxacin-induced seizures in DBA/2 mice.

Authors:  G De Sarro; F Nava; G Calapai; A De Sarro
Journal:  Antimicrob Agents Chemother       Date:  1997-02       Impact factor: 5.191

8.  Pharmacokinetic-pharmacodynamic contributions to the convulsant activity of pefloxacin and norfloxacin in rats.

Authors:  A Delon; F Huguet; P Courtois; J M Vierfond; S Bouquet; W Couet
Journal:  J Pharmacol Exp Ther       Date:  1997-02       Impact factor: 4.030

Review 9.  Antibiotic-induced convulsions.

Authors:  K L Wallace
Journal:  Crit Care Clin       Date:  1997-10       Impact factor: 3.598

10.  Comparative convulsant potencies of two carbapenem derivatives in C57 and DBA/2 mice.

Authors:  A de Sarro; C Imperatore; P Mastroeni; G de Sarro
Journal:  J Pharm Pharmacol       Date:  1995-04       Impact factor: 3.765

View more
  6 in total

1.  Lack of effect of experimental hypovolemia on imipenem muscle distribution in rats assessed by microdialysis.

Authors:  Sandrine Marchand; Claire Dahyot; Isabelle Lamarche; Elodie Plan; Olivier Mimoz; William Couet
Journal:  Antimicrob Agents Chemother       Date:  2005-12       Impact factor: 5.191

2.  Microdialysis study of imipenem distribution in skeletal muscle and lung extracellular fluids of noninfected rats.

Authors:  Sandrine Marchand; Claire Dahyot; Isabelle Lamarche; Olivier Mimoz; William Couet
Journal:  Antimicrob Agents Chemother       Date:  2005-06       Impact factor: 5.191

3.  Pharmacokinetic-pharmacodynamic modeling of electroencephalogram effect of imipenem in rats with acute renal failure.

Authors:  A Dupuis; A Limosin; J Paquereau; O Mimoz; W Couet; S Bouquet
Journal:  Antimicrob Agents Chemother       Date:  2001-12       Impact factor: 5.191

4.  Norfloxacin-induced electroencephalogram alteration and seizures in rats are not triggered by enhanced levels of intracerebral glutamate.

Authors:  Marylore Chenel; Anne Limosin; Sandrine Marchand; Joël Paquereau; Olivier Mimoz; William Couet
Journal:  Antimicrob Agents Chemother       Date:  2003-11       Impact factor: 5.191

5.  Pharmacokinetic-pharmacodynamic modeling of the electroencephalogram effect of norfloxacin in rats.

Authors:  Marylore Chenel; Agnès Barbot; Antoine Dupuis; Olivier Mimoz; Joël Paquereau; Serge Bouquet; William Couet
Journal:  Antimicrob Agents Chemother       Date:  2003-06       Impact factor: 5.191

6.  Simultaneous central nervous system distribution and pharmacokinetic-pharmacodynamic modelling of the electroencephalogram effect of norfloxacin administered at a convulsant dose in rats.

Authors:  Marylore Chenel; Sandrine Marchand; Antoine Dupuis; Isabelle Lamarche; Joël Paquereau; Claudine Pariat; William Couet
Journal:  Br J Pharmacol       Date:  2004-05       Impact factor: 8.739

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.